Monash IVF is well positioned to benefit from growing social acceptance of infertility therapies.
No-moat Monash IVF Group delivered first-half fiscal 2018 results in line with guidance provided at the annual general meeting, with net profit after tax, or NPAT, of AUD 12.1 million on group revenue of AUD 77 million, down 20.9% and 2.2%, respectively, on the prior comparable period. However, management surprised by issuing maiden guidance of a 25% NPAT decline for the full year. Notwithstanding state-specific issues across four key markets, including increased low-cost competition in Queensla...Healthbridge Enterprises is engaged in the provision of medical services in the area of human reproduction and human pathology.
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.